APA (7th ed.) Citation

Castellani, C., Colombo, C., van der Ent, C., Simmonds, N., Kinnman, N., Hassan, M., . . . Kaviya, A. (2018). PSY58 - An Observational Study of Ivacaftor in Patients with Cystic Fibrosis and Selected Non-G551D Gating Mutations in UK, Italy and Netherlands: Healthcare Resource Utilization from the First Interim Analysis of the Vocal Study. Value in Health, 21, S255. https://doi.org/10.1016/j.jval.2018.04.1717

Chicago Style (17th ed.) Citation

Castellani, C., C. Colombo, CK van der Ent, NJ Simmonds, N. Kinnman, M. Hassan, C. DeSouza, and A. Kaviya. "PSY58 - An Observational Study of Ivacaftor in Patients with Cystic Fibrosis and Selected Non-G551D Gating Mutations in UK, Italy and Netherlands: Healthcare Resource Utilization from the First Interim Analysis of the Vocal Study." Value in Health 21 (2018): S255. https://doi.org/10.1016/j.jval.2018.04.1717.

MLA (9th ed.) Citation

Castellani, C., et al. "PSY58 - An Observational Study of Ivacaftor in Patients with Cystic Fibrosis and Selected Non-G551D Gating Mutations in UK, Italy and Netherlands: Healthcare Resource Utilization from the First Interim Analysis of the Vocal Study." Value in Health, vol. 21, 2018, p. S255, https://doi.org/10.1016/j.jval.2018.04.1717.